BioAdvance
  • Home
  • About
  • Team
  • Portfolio
  • News
  • FAQ
  • Contact


News

May 03, 2003

By bioadvance


Varied Group of Researchers Gets BioAdvance Funds
Read more here

Apr 20, 2003

By bioadvance


Life-Sciences Fund Makes First 7 Loans
Read more here

Current News

  • VenatoRx Receives $9.4 Million from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Drug Resistant Bacteria
  • VenatoRx Raises $42 Million Series B: Versant, Abingworth, Foresite Back Industry-Leading Antibiotics Developer
  • Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program
  • Dr. Ottavio Vitolo Appointed Executive Clinical Advisor at Relmada Therapeutics
  • Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer

Archive

  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

© 2013-2017 BioAdvance. All rights reserved.